Tadaaki Taniguchi

1.6k total citations
31 papers, 1.3k citations indexed

About

Tadaaki Taniguchi is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Hepatology. According to data from OpenAlex, Tadaaki Taniguchi has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 9 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Hepatology. Recurrent topics in Tadaaki Taniguchi's work include Diabetes Treatment and Management (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Liver physiology and pathology (5 papers). Tadaaki Taniguchi is often cited by papers focused on Diabetes Treatment and Management (7 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Liver physiology and pathology (5 papers). Tadaaki Taniguchi collaborates with scholars based in Japan, United States and Croatia. Tadaaki Taniguchi's co-authors include Yutaka Yamamoto, Masakazu Toi, Takeshi Tominaga, Hideo Suzuki, Shinichi Kondo, Juan Camilo Arjona Ferreira, John M. Amatruda, Kenji Nonaka, Naoko Tajima and Takashi Kadowaki and has published in prestigious journals such as Cancer, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

Tadaaki Taniguchi

31 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tadaaki Taniguchi Japan 18 738 428 352 306 182 31 1.3k
Sonia Bergaya France 14 627 0.8× 650 1.5× 240 0.7× 168 0.5× 122 0.7× 15 1.9k
Masaharu Yamazaki Japan 22 453 0.6× 175 0.4× 310 0.9× 165 0.5× 469 2.6× 57 1.3k
Akihiko Takeda Japan 21 709 1.0× 541 1.3× 264 0.8× 163 0.5× 100 0.5× 55 1.8k
Gui‐Qi Zhu China 26 646 0.9× 382 0.9× 475 1.3× 117 0.4× 421 2.3× 78 2.0k
Yukihiko Matsuda Japan 17 622 0.8× 457 1.1× 340 1.0× 47 0.2× 269 1.5× 38 1.4k
Shuichi Iwahashi Japan 25 543 0.7× 517 1.2× 281 0.8× 113 0.4× 368 2.0× 85 1.7k
Lawrence A. Shirley United States 21 525 0.7× 577 1.3× 239 0.7× 199 0.7× 182 1.0× 48 1.5k
Robert X.-D. Song United States 17 807 1.1× 574 1.3× 206 0.6× 286 0.9× 24 0.1× 19 1.8k
Yukihiro Hojo Japan 25 604 0.8× 205 0.5× 241 0.7× 115 0.4× 30 0.2× 56 1.6k
Heather Francis United States 21 407 0.6× 179 0.4× 266 0.8× 67 0.2× 302 1.7× 33 1.1k

Countries citing papers authored by Tadaaki Taniguchi

Since Specialization
Citations

This map shows the geographic impact of Tadaaki Taniguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadaaki Taniguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadaaki Taniguchi more than expected).

Fields of papers citing papers by Tadaaki Taniguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadaaki Taniguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadaaki Taniguchi. The network helps show where Tadaaki Taniguchi may publish in the future.

Co-authorship network of co-authors of Tadaaki Taniguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Tadaaki Taniguchi. A scholar is included among the top collaborators of Tadaaki Taniguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadaaki Taniguchi. Tadaaki Taniguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kadowaki, Takashi, et al.. (2012). Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks. Journal of Diabetes Investigation. 4(2). 174–181. 20 indexed citations
2.
Kashiwagi, Atsunori, Takashi Kadowaki, Naoko Tajima, et al.. (2011). Sitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetes. Journal of Diabetes Investigation. 2(5). 381–390. 20 indexed citations
3.
Iwamoto, Yasuhiko, Naoko Tajima, Takashi Kadowaki, et al.. (2010). Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double‐blind trial. Diabetes Obesity and Metabolism. 12(7). 613–622. 89 indexed citations
4.
Horie, Yoshiharu, Mamoru Narukawa, Kenji Nonaka, et al.. (2009). Predicting steady‐state HbA 1c responses to sitagliptin in patients with type 2 diabetes mellitus*. Diabetes Obesity and Metabolism. 11(8). 813–818. 2 indexed citations
5.
Ikeda, Takanori, et al.. (2006). . Folia Pharmacologica Japonica. 127(6). 495–502. 1 indexed citations
6.
Kinoshita, Hiroshi, Tadaaki Taniguchi, Akira Kubota, et al.. (2005). An Autopsy Case of Imipramine Poisoning. American Journal of Forensic Medicine & Pathology. 26(3). 271–274. 2 indexed citations
7.
Kinoshita, Hiroshi, Tadaaki Taniguchi, Takao Utsumi, et al.. (2003). An autopsy case of combined drug intoxication involving verapamil, metoprolol and digoxin. Forensic Science International. 133(1-2). 107–112. 17 indexed citations
8.
Ueno, Takayuki, M. Toi, Tadaaki Taniguchi, & T. Tominaga. (1998). Serum hepatocyte growth factor levels in breast cancer patients with distant metastases. 11(3). 147–152. 1 indexed citations
9.
Taniguchi, Tadaaki, M Kitamura, K Arai, et al.. (1997). Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. British Journal of Cancer. 75(5). 673–677. 60 indexed citations
10.
Hatake, Kiyohiko, et al.. (1997). Liver cytosolic aldehyde dehydrogenase (ALDH1) polymorphism and its inheritance in Wistar rats.. PubMed. 32(3). 182–8. 4 indexed citations
11.
Kondo, Shinichi, Hideo Suzuki, Yutaka Yamamoto, et al.. (1996). Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer. 77(6). 1101–1106. 167 indexed citations
12.
Toi, Masakazu, et al.. (1996). Clinical significance of the determination of angiogenic factors. European Journal of Cancer. 32(14). 2513–2519. 79 indexed citations
13.
Toi, Masakazu, Tadaaki Taniguchi, Ken Hayashi, & T. Tominaga. (1995). [The effect of combination treatment consisted of 5'-deoxy-5-fluorouridine and medroxyprogesterone acetate for recurrent breast cancer patient].. PubMed. 22(6). 799–804. 1 indexed citations
14.
Taniguchi, Tadaaki, et al.. (1995). Serum concentrations of hepatocyte growth factor in breast cancer patients.. PubMed. 1(9). 1031–4. 86 indexed citations
15.
Hatake, Katsuhiko, Ichiro Wakabayashi, Tadaaki Taniguchi, & Shigeru Hishida. (1994). Increased Endothelium‐Dependent Vascular Relaxation in Ethanol‐Fed Rats. Alcoholism Clinical and Experimental Research. 18(4). 1018–1023. 17 indexed citations
16.
Taniguchi, Tadaaki, Masakazu Toi, & T. Tominaga. (1994). INCREASE IN THE CIRCULATING LEVEL OF HEPATOCYTE GROWTH-FACTOR IN BREAST-CANCER PATIENTS WITH DISTANT METASTASES. Oncology Reports. 1(6). 1199–201. 5 indexed citations
17.
Hishida, Shigeru, et al.. (1993). Effects of daily administration of methamphetamine on multiple active/passive avoidance performance in rats. Behavioural Brain Research. 53(1-2). 105–112. 2 indexed citations
18.
Hishida, Shigeru, et al.. (1992). Effects of methamphetamine and ethanol on learning and brain neurotransmitters in rats. Pharmacology Biochemistry and Behavior. 42(3). 389–400. 18 indexed citations
19.
Kakishita, Eizo, et al.. (1991). Development of Tolerance to Inhibitory Effect of Ethanol on Endothelium‐dependent Vascular Relaxation in Ethanol‐fed Rats. Alcoholism Clinical and Experimental Research. 15(1). 112–115. 22 indexed citations
20.
Taniguchi, Tadaaki, et al.. (1990). Possible involvement of kinins in cardiovascular changes after alcohol intake. Pharmacology Biochemistry and Behavior. 35(2). 437–442. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sonia Bergaya Breakdown of academic impact, for papers by Masaharu Yamazaki Breakdown of academic impact, for papers by Akihiko Takeda Breakdown of academic impact, for papers by Gui‐Qi Zhu Breakdown of academic impact, for papers by Yukihiko Matsuda Breakdown of academic impact, for papers by Shuichi Iwahashi Breakdown of academic impact, for papers by Lawrence A. Shirley Breakdown of academic impact, for papers by Robert X.-D. Song Breakdown of academic impact, for papers by Yukihiro Hojo Breakdown of academic impact, for papers by Heather Francis
Rankless by CCL
2026